Free Trial
NASDAQ:NARI

Inari Medical (NARI) Stock Price, News & Analysis

Inari Medical logo
$79.97 0.00 (0.00%)
As of 02/19/2025

About Inari Medical Stock (NASDAQ:NARI)

Key Stats

Today's Range
$79.97
$79.97
50-Day Range
$79.97
$79.97
52-Week Range
$39.76
$79.99
Volume
N/A
Average Volume
1.30 million shs
Market Capitalization
$4.68 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.22
Consensus Rating
Hold

Company Overview

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

NARI Stock News Headlines

What President Trump’s Executive Order 14154 means for your money
Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.
Stryker concludes Inari Medical acquisition for $4.9bn
See More Headlines

NARI Stock Analysis - Frequently Asked Questions

Inari Medical's stock was trading at $51.05 at the beginning of the year. Since then, NARI shares have increased by 56.7% and is now trading at $79.97.
View the best growth stocks for 2025 here
.

Inari Medical, Inc. (NASDAQ:NARI) announced its earnings results on Wednesday, February, 28th. The company reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.09. Inari Medical's revenue was up 22.5% compared to the same quarter last year.
Read the conference call transcript
.

Inari Medical (NARI) raised $110 million in an IPO on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.

Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inari Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Tesla (TSLA), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
2/28/2024
Today
5/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NARI
Fax
N/A
Employees
800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$69.22
High Stock Price Target
$80.00
Low Stock Price Target
$47.00
Potential Upside/Downside
-13.4%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
14 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,640,000.00
Pretax Margin
-9.29%

Debt

Sales & Book Value

Annual Sales
$493.63 million
Cash Flow
$0.09 per share
Price / Cash Flow
906.95
Book Value
$8.07 per share
Price / Book
9.91

Miscellaneous

Free Float
52,338,000
Market Cap
$4.68 billion
Optionable
Optionable
Beta
1.02
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:NARI) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners